Intellectual property portfolio now includes five pending provisionals and one pending non-provisional patent application OXFORD, Ohio and COCONUT CREEK, Fla., July 13, 2021 /CNW/ – PsyBio Therapeutics Corp. (TSXV: PSYB) (OTC: PSYBF) (“PsyBio” or the “Company“), an intellectual property driven biotechnology company developing novel formulations of psychoactive medications produced by genetically…


Previous articleWesana Health Announces Definitive Agreement to Acquire PsyTech Inc.
Next articlePsychedelic Research Bulletin: June 2021